RIDR-PI-103

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameRIDR-PI-103
Drug Alias NameRIDR-PI-103
ClassificationOther
Mechanisms of Action +[1N/A
TargetsPI3-kinase class I
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cincinnati
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Cincinnati
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A